皇家华人

header-logo
GettyImages-609179959-hero
headshot

Ariel Nelson, MD, MS

Assistant Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English

Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine
  • MS -Master of Science

Publications

  • (Vineel Bhatlapenumarthi, Navonil De Sarkar, Anannya Patwari, Emmanuel S. Antonarakis, Ariel Ann Nelson, Deepak Kilari.) J Clin Oncol. J Clin Oncol 42, 2024 (suppl 4; abstr 206) 02/25/2024

  • (David H Aggen, Alejandro Garcia, Jose M Saro Suarez, Amy Sauer, Sebastiano Cristiani, Francine Elizabeth Brophy, Sharon Streets, Elliot Norry, Ariel Ann Nelson, Deepak Kilari, Benjamin Garmezy, John A. Charlson, Jon Zugazagoitia, Emiliano Calvo, Irene Moreno, Victor Moreno, Christopher J. Hoimes, David S. Hong, Andres Cervantes.) J Clin Oncol. J Clin Oncol 42, 2024 (suppl 4; abstr TPS708) 02/25/2024

  • (Bicky Thapa, Ariel Nelson & Deepak Kilari.) . Thapa, B., Nelson, A., Kilari, D. (2023). Novel Targets in Development for Advanced Renal Cell Carcinoma. In: McKay, R.R., Singer, E.A. (eds) Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma. Springer, Cham. https://doi.org/10.1007/978-3-031-40901-1_14 11/02/2023

  • (Mirsky MM, Mitchell C, Hong A, Cao S, Fu P, Margevicius S, Wu S, Dowlati A, Nelson A, Selfridge JE, Ramaiya N, Hoimes C, Alahmadi A, Bruno DS.) Cancer Manag Res. 2023;15:913-927 PMID: 37674660 PMCID: PMC10478776 09/07/2023

  • (Katy Beckermann, Matthew T Campbell, Naomi B. Haas, Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao, Hans J. Hammers, Saby George, Ariel Ann Nelson, Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad, Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller, Martin H Voss, Brian I. Rini, Neil J. Shah.) J Clin Oncol . J Clin Oncol 41, 2023 (suppl 16; abstr 4534) 07/01/2023

  • (Ariel Ann Nelson, Kristin Riemersma, Kathryn A. Bylow, Michael Holt, Deepak Kilari.) J Clin Oncol . J Clin Oncol 41, 2023 (suppl 16; abstr e17065) 07/01/2023

  • (Ariel Ann Nelson, Christina Ladwig, Kristin Riemersma, Kathryn A. Bylow, Deepak Kilari.) J Clin Oncol . J Clin Oncol 41, 2023 (suppl 16; abstr e18671) 07/01/2023

  • (Katy Beckermann, Matthew T Campbell, Naomi B. Haas, Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao, Hans J. Hammers, Saby George, Ariel Ann Nelson, Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad, Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller, Martin H Voss, Brian I. Rini, Neil J. Shah.) Journal of Clinical Oncology . J Clin Oncol 41, 2023 (suppl 16; abstr 4534) 06/02/2023

  • (Ariel Ann Nelson, Aniko Szabo, Deepak Kilari.) Journal of Clinical Oncology . J Clin Oncol 41, 2023 (suppl 6; abstr 730) 06/02/2023

  • (Michael Pierro, Ariel Ann Nelson, John Xie, Albert Jang, Kathryn A. Bylow, Pedro C. Barata, Colleen Anne Lawton, Deepak Kilari.) J Clin Oncol . J Clin Oncol 41, 2023 (suppl 6; abstr 67) 03/16/2023

  • (Ariel Ann Nelson, Mariel Molina Nunez, Kathryn A. Bylow, Aniko Szabo, Kenneth Iczkowski, Deepak Kilari.) Journal of Clinical Oncology . Journal of Clinical Oncology 41, no. 6_suppl (February 20, 2023) 557-557. 02/21/2023

  • (Mirsky MM, Mitchell C, Hong A, Cao S, Fu P, Margevicius S, Wu S, Dowlati A, Nelson A, Eva Selfridge J, Ramaiya N, Hoimes C, Alahmadi A, Bruno DS.) Cancer Management and Research. 2023;15:913-927 SCOPUS ID: 2-s2.0-85170261753 01/01/2023

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.